Congratulations to LaTonya J. Hickson, Sandra M. Herrmann, Bairbre A. McNicholas and Matthew D. Griffin on their recent paper: Progress toward the clinical application of mesenchymal stromal cells and other disease-modulating regenerative therapies. The paper was published online in Kidney360 yesterday, January 27, 2021. Reference: Kidney360 January 2021, 10.34067/KID.0005692020; DOI: https://doi.org/10.34067/KID.0005692020.
This author has yet to write their bio.
Meanwhile lets just say that we are proud nephstrom_admin contributed a whooping 63 entries.
‘Tolerance to Bone Marrow Transplantation: Do Mesenchymal Stromal Cells Still Have a Future for Acute or Chronic GvHD?’ was published today in Frontiers in Immunology. NEPHSTROM PIs Drs Martino Introna and Josée Golay of the Center of Cellular Therapy “G. Lanzani”, Division of Haematology, Azienda Socio-Sanitaria Territoriale Papa Giovanni XXIII announced the publication of this […]
Professor Matthew Griffin of the National University of Ireland in Galway delivered lectures presenting NEPHSTROM research at a range of international venues in recent months. Below, find the titles of his talks, with the date, and audience composition. “Diabetic Kidney Disease: The Promise of Regenerative Therapies”. REMEDI Seminar. Biomedical Sciences, NUI Galway Date: May 23rd […]
Coordinator Prof Tim O’Brien from NUI Galway presented aspects of NEPHSTROM at a recent Marie Curie Innovative Training Network workshop hosted in Galway. Coordinator O’Brien’s talk was entitled, “MSCs as a Therapy for Diabetic Complications.“ The online workshop was held on October 13th and 14th. RenalToolBox, the ITN hosting the workshop, is taking a coordinated approach to […]
The NEPHSTROM Galway trial team has developed a new trial visit workflow to meet the public health guidelines for COVID-19 protection for patients. They were able to successfully complete the end-of-study visit protocol for one of the NEPHSTROM patients and will complete further trial visits in a similar manner in July. Prof Matthew Griffin, of NUI […]
NEPHSTROM partner Leiden University Medical Center (LUMC) will begin construction of the largest non-profit stem cell and gene therapy facility in the Netherlands in 2020. This will be one of the largest such facilities in Europe measuring at 4000 square metres. The Leiden facility is called NECSTGEN, the Netherlands Centre for the Clinical advancement of […]
NEPHSTROM results were presented at EU-MSC2, a bi-annual event, organized by partners Leiden University Medical Center in The Netherlands. The meeting assembles researchers, clinicians and cell product developers working within EU-sponsored research consortia, that focus on mesenchymal stromal cell (MSC) therapy for immune-related disorders and tissue regeneration. EU-MSC2, a much-anticipated event provides excellent opportunities for networking, […]
Congratulations to NEPHSTROM partners at the Centre for Public Health, Queen’s University Belfast, the University Hospitals Birmingham, and the National University of Ireland Galway for their recent review: The impact of chronic kidney disease on developed countries from a health economics perspective: A systematic scoping review published in PLoS ONE. Sarah Elshahat, Paul Cockwell, Alexander P. […]
The NEPHSTROM consortium reached a significant milestone when they held the tenth plenary project meeting in Dublin on January 30th, 2020. The meeting was hosted by Pintail Limited, and coincided with the successful treatment of the final patient to be included in the low dose cohort of the clinical trial and provided an opportunity for […]
- Contract/Grant agreement number
- EC contribution
- Starting date
1 May 2015
- NEPHSTROM study published in Kidney360 journal 28th January 2021
- Drs Martino Introna and Josée Golay publish NEPHSTROM research in Frontiers in Immunology 11th December 2020
- NUI Galway’s Prof Matt Griffin presents NEPHSTROM to an array of international audiences 27th October 2020
- NEPHSTROM presented at RenalToolBox ITN Workshop, Galway 21st October 2020
- NEPHSTROM Galway trial team adapts to new patient safety needs 17th June 2020
- National University of Ireland, Galway
- Academisch Ziekenhuis Leiden – Leids Universitair Medisch Centrum
- Orbsen Therapeutics
- Ludwig-Maximilians-Universitaet Muenchen
- Istituto di Ricerche Farmacologiche Mario Negri
- NHS Blood and Transplant
- University Hospital Birmingham NHS Foundation Trust
- The Belfast Health and Social Care Trust
- Pintail Ltd
- Terumo BCT Europe N.V.
- Azienda Ospedaliera Papa Giovanni XXIII Bergamo
- Queen’s University Belfast